News

Visiting Chinese researcher strengthens TB collaboration

Burnet Institute

04 February, 2013

Ms Hongmei Liu and Kye Mohd Hanafiah in the Diagnostics Development Laboratory.

A visiting researcher from China has spent four weeks training at Burnet as part of an ongoing collaboration with the Institute for Pathogen Biology (IPB) in developing diagnostics for active pulmonary tuberculosis.

IPB, a member of the Chinese Academy of Medical Sciences, is a national centre of excellence for the study of important human pathogens, responsible for advancing knowledge and technology for better diagnosis, treatment, and prevention of infectious diseases in China.

Ms Hongmei Liu has been working with Kye Mohd Hanafiah from Burnet’s Diagnostics Development Laboratory learning techniques of a novel diagnostic assay.

Associate Professor David Anderson, Head of the Diagnostics Development Laboratory says the collaboration with IPB will focus on novel diagnostic methods, especially for use in resource-poor settings, will hopefully provide improved tools for detecting individuals with active TB, who can then be investigated for appropriate drug treatment.

“Both aspects are necessary to achieve effective control of this disease in the absence of an improved vaccine,” Associate Professor Anderson said.

“In the long term, the Burnet’s plans towards the establishment of a TB vaccine program will be enhanced by sharing knowledge with IPB – we are confident that Hongmei’s visit to our labs will be the first of many steps on this journey.”

Head of Burnet’s China Program, Lisa Renkin said Hongmei’s visit was made possible through funding from the Australia-China Council, which is supporting further exchanges between IPB and Burnet laboratory scientists and symposia in both Beijing and Melbourne.

“Following Hongmei’s successful and productive visit to Melbourne, two of Burnet’s research scientists will travel to Beijing and spend time in the IPB laboratories, continuing our collaborative search for novel biomarkers,” Ms Renkin said.

“If the planned experiments are successful, we will seek further funding to undertake field trials in China.”

Contact Details

For more information in relation to this news article, please contact:

Associate Professor David Anderson

Deputy Director (Partnerships), Burnet Institute; Co-Head, Global Health Diagnostics Development

Telephone

+61392822239

Email

david.anderson@burnet.edu.au

Subscribe to News

Subscribe to receive our latest news: